Skip to main content
70°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Oculis Holding AG - Ordinary shares
(NQ:
OCS
)
17.22
+0.06 (+0.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oculis Holding AG - Ordinary shares
< Previous
1
2
Next >
Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
September 04, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
September 01, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis to Participate in Upcoming September Investor Conferences
August 28, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Uncovering Potential: Oculis Holding's Earnings Preview
August 20, 2025
Via
Benzinga
Expert Ratings for Oculis Holding
November 17, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Oculis Holding
October 05, 2023
Via
Benzinga
This CoreWeave Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
August 27, 2025
Via
Benzinga
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
August 25, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis Reports Q2 2025 Financial Results and Provides Company Update
August 21, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Earnings Scheduled For August 21, 2025
August 21, 2025
Via
Benzinga
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
August 12, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis Upsized Loan Facility to Access up to CHF 100 million
August 01, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis Publishes Results of 2025 Annual General Meeting
June 05, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis to Participate in Upcoming June Investor Conferences
June 03, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis Publishes Invitation to the Annual General Meeting
May 09, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
May 09, 2025
Via
Benzinga
Oculis Reports Q1 2025 Financial Results and Provides Company Update
May 08, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis to Present at Upcoming May Investor Conferences
May 07, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences
May 01, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
April 17, 2025
Via
Benzinga
Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award
April 17, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
April 15, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond
April 01, 2025
From
Oculis Holding AG
Via
GlobeNewswire
TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday
January 10, 2025
Via
Benzinga
Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy
January 06, 2025
From
Oculis Holding AG
Via
GlobeNewswire
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 15, 2024
Via
Benzinga
Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday
June 11, 2024
Via
Benzinga
OCS Stock Earnings: Oculis Holding Misses EPS, Misses Revenue for Q1 2024
May 18, 2024
OCS stock results show that Oculis Holding missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
FLJ Group, Bit Digital And Other Big Stocks Moving Higher In Friday's Pre-Market Session
December 29, 2023
U.S. stock futures were slightly higher this morning, with the Dow Jones futures gaining around 15 points on Thursday. Shares of FLJ Group Limited(NASDAQ: FLJ) rose sharply in pre-market trading.
Via
Benzinga
Topics
Stocks
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
October 05, 2023
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.